Showing results (1-10 of 298) with videos related to
Sort By:
Pageof 30
World Journal of Gastrointestinal Oncology|August 2, 2019
Recent progress of chemotherapy and biomarkers for gastroesophageal cancerOsamu Maeda, Yuichi AndoJapanese Journal of Clinical Oncology|December 13, 2025
Efficacy and safety of immune checkpoint inhibitor rechallenge following immune-related adverse events: a reviewKazuyuki Mizuno, Osamu Maeda, Yuichi AndoJapanese Journal of Clinical Oncology|January 6, 2024
Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitorsYao Liang, Osamu Maeda, Yuichi AndoPlos One|August 11, 2025
Correction: Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinomaYao Liang, Osamu Maeda, Chiaki Kondo, et al.Cancer Science|January 31, 2025
Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitorsYao Liang, Osamu Maeda, Kazuki Nishida, et al.Plos One|July 22, 2024
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinomaYao Liang, Osamu Maeda, Chiaki Kondo, et al.Nagoya Journal of Medical Science|March 29, 2016
Nivolumab for the treatment of malignant melanoma in a patient with pre-existing myasthenia gravisOsamu Maeda, Kenji Yokota, Naoki Atsuta, et al.Molecular and Clinical Oncology|July 11, 2019
Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapyOsamu Maeda, Ayumu Matsuoka, Kazuhiro Furukawa, et al.Cancer Chemotherapy and Pharmacology|July 2, 2025
Pazopanib and antacids: insights from the WHO pharmacovigilance databaseKazuki Nishida, Yao Liang, Osamu Maeda, et al.Cancer Science|March 8, 2026
FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel for Pancreatic Cancer by BRCA2 and TMB Status: A Japanese C-CAT Database StudyKazuyuki Mizuno, Takuya Ishikawa, Takanori Ito, et al.Pageof 30